risedronic acid has been researched along with Aging in 11 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These findings indicated that the long-term administration of PGE2 alone cannot maintain or continue to add bone mass in ovx rats but that co-treatment of a PGE2 with an anti-resorptive or activation agent can resist the influence of the mechanostat induced bone loss as well as continue to add bone." | 1.29 | Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. ( Chen, YY; Ijiri, K; Jee, WS; Ke, HZ; Ma, Y, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugie-Oya, A | 1 |
| Takakura, A | 1 |
| Takao-Kawabata, R | 1 |
| Sano, H | 1 |
| Shimazu, Y | 1 |
| Isogai, Y | 1 |
| Yamaguchi, A | 1 |
| Ishizuya, T | 1 |
| Verhaar, HJ | 1 |
| Ito, M | 1 |
| Nakayama, K | 1 |
| Konaka, A | 1 |
| Sakata, K | 1 |
| Ikeda, K | 1 |
| Maruyama, T | 1 |
| Jee, WS | 5 |
| Lin, BY | 2 |
| Ma, YF | 3 |
| Ke, HZ | 5 |
| Li, QN | 1 |
| Xie, H | 1 |
| Huang, LF | 1 |
| Liang, NC | 1 |
| Ma, Y | 1 |
| Chen, YY | 2 |
| Ijiri, K | 1 |
| Lin, CH | 1 |
| Li, XJ | 1 |
| Mosekilde, L | 2 |
| Thomsen, JS | 2 |
| McOsker, JE | 1 |
| Trémollières, F | 1 |
| Iwaniec, UT | 1 |
| Mitova-Caneva, NG | 1 |
| Wronski, TJ | 1 |
| Tang, LY | 1 |
| Kimmel, DB | 1 |
1 review available for risedronic acid and Aging
| Article | Year |
|---|---|
[Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Topics: Aging; Alendronate; Diphosphonates; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Mi | 2001 |
10 other studies available for risedronic acid and Aging
| Article | Year |
|---|---|
Comparison of treatment effects of teriparatide and the bisphosphonate risedronate in an aged, osteopenic, ovariectomized rat model under various clinical conditions.
Topics: Aging; Animals; Bone Diseases, Metabolic; Disease Models, Animal; Female; Lumbar Vertebrae; Ovariect | 2016 |
[Treatment of osteoporosis in the elderly: what is the evidence?].
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alendronate; Bone Density; Bone Density Conservation Ag | 2008 |
Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
Topics: Aging; Animals; Bone Density; Etidronic Acid; Female; Heptanoates; Ovariectomy; Prostaglandins E; Ra | 2006 |
Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
Topics: Aging; Analysis of Variance; Animals; Body Weight; Bone Development; Bone Resorption; Calcium Channe | 1995 |
Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
Topics: Aging; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Interactions; Etidronic Acid; Femal | 1995 |
Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
Topics: Aging; Animals; Body Weight; Bone Development; Bone Diseases, Metabolic; Dinoprostone; Drug Therapy, | 1995 |
Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
Topics: Age Factors; Aging; Animals; Bone and Bones; Bone Density; Calcium Channel Blockers; Dinoprostone; D | 1997 |
No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.
Topics: Aging; Animals; Biomechanical Phenomena; Bone and Bones; Bone Diseases, Metabolic; Calcium Channel B | 1997 |
Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Topics: Aging; Animals; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Ca | 2002 |
Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
Topics: Aging; Animals; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption | 1992 |